Join us for the next NU-HTA User Spotlight Seminar, ‘Repurposing Chemotherapies Against Meningiomas’ with Craig Horbinski, MD, PhD, Professor of Pathology and Director of Neuropathology in the Department of Pathology in the Feinberg School of Medicine.

Using patient-derived meningioma cells, Horbinski and team screened a large panel of FDA-approved chemotherapies to identify candidates for repurposing against meningioma, tumors that arises from the membranes surrounding the brain and spinal cord.

Note – This program was originally scheduled to take place in-person and online. Due to COVID-19 safety precautions, the program will switch to 100% online.

Jan 24, 2022 12:00 PM in Central Time (US and Canada)

Registration: https://northwestern.zoom.us/meeting/register/tJckduGtrTssGdWFKQlw5An74625AjY8iUSE